Skip to main content

Table 7 Relationship between RAR and the risk of carotid plaques according to different glucose regulation state and age

From: Relationship between red cell distribution width/albumin ratio and carotid plaque in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China

Glucose regulation state

Age

Variables

Carotid artery plaques

OR (95% CI)a

P-value

OR (95% CI)b

P-value

OR (95% CI)c

P-value

OR (95% CI)d

P-value

Normal glucose regulation

< 60

RAR

1.46 (1.10, 1.94)

0.009

1.50 (1.10, 2.04)

0.011

1.55 (1.13, 2.13)

0.007

1.51 (1.06, 2.16)

0.022

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

1.09 (0.80, 1.50)

0.578

1.09 (0.78, 1.53)

0.618

1.07 (0.76, 1.51)

0.695

1.06 (0.75, 1.51)

0.743

Q3

1.11 (0.79, 1.55)

0.552

1.10 (0.77, 1.57)

0.612

1.08 (0.75, 1.56)

0.673

1.05 (0.72, 1.53)

0.808

Q4

1.56 (1.09, 2.24)

0.016

1.63 (1.10, 2.40)

0.014

1.67 (1.12, 2.49)

0.011

1.62 (1.05, 2.49)

0.028

≥ 60

RAR

1.40 (1.12, 1.76)

0.003

1.28 (1.01, 1.61)

0.040

1.23 (0.97, 1.57)

0.084

1.26 (0.97, 1.64)

0.080

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

1.00 (0.76, 1.32)

0.999

1.02 (0.76, 1.37)

0.886

1.03 (0.77, 1.38)

0.847

1.03 (0.76, 1.38)

0.873

Q3

1.15 (0.86, 1.53)

0.340

1.09 (0.81, 1.46)

0.576

1.06 (0.78, 1.44)

0.707

1.04 (0.77, 1.41)

0.796

Q4

1.50 (1.13, 2.01)

0.006

1.41 (1.04, 1.90)

0.025

1.35 (0.99, 1.85)

0.056

1.38 (1.00, 1.91)

0.051

Prediabetes

< 60

RAR

1.05 (0.78, 1.42)

0.736

1.08 (0.79, 1.48)

0.645

1.10 (0.79, 1.53)

0.570

1.20 (0.81, 1.79)

0.372

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

1.05 (0.73, 1.50)

0.812

1.01 (0.69, 1.49)

0.950

1.04 (0.71, 1.54)

0.827

1.08 (0.72, 1.61)

0.704

Q3

0.83 (0.56, 1.23)

0.357

0.89 (0.59, 1.36)

0.599

0.90 (0.59, 1.37)

0.617

0.90 (0.59, 1.40)

0.651

Q4

1.02 (0.66, 1.56)

0.947

1.04 (0.66, 1.64)

0.854

1.07 (0.67, 1.70)

0.793

1.20 (0.71, 2.04)

0.495

≥ 60

RAR

1.22 (0.95, 1.56)

0.113

1.23 (0.95, 1.58)

0.119

1.22 (0.94, 1.59)

0.126

1.23 (0.92, 1.64)

0.163

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

1.11 (0.82, 1.51)

0.511

1.19 (0.87, 1.64)

0.269

1.19 (0.87, 1.64)

0.273

1.20 (0.87, 1.65)

0.269

Q3

1.35 (0.99, 1.84)

0.056

1.39 (1.01, 1.91)

0.041

1.35 (0.98, 1.86)

0.069

1.37 (0.99, 1.90)

0.056

Q4

1.27 (0.94, 1.73)

0.124

1.34 (0.98, 1.84)

0.071

1.33 (0.96, 1.85)

0.083

1.33 (0.95, 1.87)

0.100

Diabetes

< 60

RAR

1.37 (1.04, 1.82)

0.027

1.45 (1.08, 1.96)

0.015

1.64 (1.20, 2.24)

0.002

1.59 (1.13, 2.24)

0.008

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

1.26 (0.90, 1.76)

0.176

1.30 (0.91, 1.84)

0.145

1.31 (0.92, 1.87)

0.139

1.31 (0.92, 1.88)

0.140

Q3

1.00 (0.71, 1.42)

0.998

1.01 (0.71, 1.46)

0.944

1.12 (0.78, 1.63)

0.537

1.09 (0.75, 1.59)

0.653

Q4

1.70 (1.15, 2.52)

0.008

1.84 (1.22, 2.77)

0.004

2.16 (1.41, 3.30)

< 0.001

2.10 (1.33, 3.33)

0.002

≥ 60

RAR

1.39 (1.11, 1.75)

0.005

1.43 (1.12, 1.81)

0.004

1.52 (1.19, 1.94)

0.001

1.35 (1.03, 1.76)

0.031

Q1

Reference

 

Reference

 

Reference

 

Reference

 

Q2

0.83 (0.62, 1.12)

0.220

0.84 (0.62, 1.14)

0.260

0.83 (0.61, 1.13)

0.242

0.83 (0.61, 1.12)

0.219

Q3

0.91 (0.69, 1.22)

0.535

0.95 (0.71, 1.27)

0.712

0.95 (0.71, 1.28)

0.740

0.91 (0.67, 1.23)

0.530

Q4

1.31 (0.97, 1.78)

0.078

1.34 (0.98, 1.83)

0.065

1.39 (1.02, 1.91)

0.040

1.23 (0.88, 1.71)

0.219

  1. aModel1: unadjusted
  2. bModel2: adjusted for sex, SBP, DBP
  3. cModel3: adjusted for sex, SBP, DBP, TC, TG, smoking, drinking, use of antihypertensives, use of antilipidemic
  4. dModel4: adjusted for sex, SBP, DBP, TC, TG, smoking, drinking, use of antihypertensives, use of antilipidemic, haematologic, rheumatical, WBC, CRP, Hb
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840